Kotra Industries Berhad (0002.KL)
MYR 4.15
(0.0%)
MYR 4.15
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 70.78 Million MYR | -12.83% |
| 2022 | 80.89 Million MYR | 12.65% |
| 2021 | 73.44 Million MYR | 66.66% |
| 2020 | 43.03 Million MYR | -2.12% |
| 2019 | 43.49 Million MYR | 17.06% |
| 2018 | 37.73 Million MYR | 12.2% |
| 2017 | 34.24 Million MYR | 7.72% |
| 2016 | 31.89 Million MYR | 12.36% |
| 2015 | 28.1 Million MYR | 32.71% |
| 2014 | 21.2 Million MYR | -16.61% |
| 2013 | 25.39 Million MYR | 10.87% |
| 2012 | 22.9 Million MYR | 15.67% |
| 2011 | 19.59 Million MYR | 135.09% |
| 2010 | 8.33 Million MYR | -48.76% |
| 2009 | 16.26 Million MYR | 33.59% |
| 2008 | 12.17 Million MYR | 16.5% |
| 2007 | 10.47 Million MYR | -9.31% |
| 2006 | 11.55 Million MYR | 0.13% |
| 2005 | 11.5 Million MYR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | 20.29 Million MYR | 29.07% |
| 2023 Q3 | 15.72 Million MYR | 1.55% |
| 2023 FY | - MYR | -12.83% |
| 2023 Q2 | 15.48 Million MYR | -11.83% |
| 2023 Q1 | 17.56 Million MYR | 2.38% |
| 2022 Q1 | 22.09 Million MYR | 36.86% |
| 2022 Q2 | 20.28 Million MYR | -8.19% |
| 2022 Q3 | 21.39 Million MYR | 5.49% |
| 2022 Q4 | 17.15 Million MYR | -19.82% |
| 2022 FY | - MYR | 12.65% |
| 2021 Q1 | 18.73 Million MYR | 2.09% |
| 2021 Q3 | 20.9 Million MYR | 18.21% |
| 2021 Q4 | 16.14 Million MYR | -22.79% |
| 2021 FY | - MYR | 66.66% |
| 2021 Q2 | 17.68 Million MYR | -5.6% |
| 2020 Q1 | 6.8 Million MYR | -20.56% |
| 2020 Q3 | 10.44 Million MYR | 39.92% |
| 2020 FY | - MYR | -2.12% |
| 2020 Q4 | 18.35 Million MYR | 75.76% |
| 2020 Q2 | 7.46 Million MYR | 9.67% |
| 2019 Q4 | 8.56 Million MYR | -28.84% |
| 2019 FY | - MYR | 17.06% |
| 2019 Q3 | 12.03 Million MYR | -10.04% |
| 2019 Q1 | 9.54 Million MYR | -1.8% |
| 2019 Q2 | 13.38 Million MYR | 40.25% |
| 2018 Q2 | 8.97 Million MYR | -7.58% |
| 2018 FY | - MYR | 12.2% |
| 2018 Q4 | 9.71 Million MYR | 3.77% |
| 2018 Q3 | 9.36 Million MYR | 4.3% |
| 2018 Q1 | 9.71 Million MYR | -4.07% |
| 2017 Q3 | 8.33 Million MYR | -4.99% |
| 2017 Q2 | 8.77 Million MYR | 24.54% |
| 2017 FY | - MYR | 7.72% |
| 2017 Q1 | 7.04 Million MYR | 3.27% |
| 2017 Q4 | 10.12 Million MYR | 21.51% |
| 2016 Q3 | 9.41 Million MYR | -11.11% |
| 2016 FY | - MYR | 12.36% |
| 2016 Q4 | 6.81 Million MYR | -27.6% |
| 2016 Q2 | 10.59 Million MYR | 108.42% |
| 2016 Q1 | 5.08 Million MYR | -36.47% |
| 2015 Q2 | 5.61 Million MYR | -35.3% |
| 2015 Q1 | 8.67 Million MYR | 45.45% |
| 2015 Q3 | 5.84 Million MYR | 4.19% |
| 2015 Q4 | 8 Million MYR | 36.88% |
| 2015 FY | - MYR | 32.71% |
| 2014 Q4 | 5.96 Million MYR | 3.72% |
| 2014 Q3 | 5.74 Million MYR | -21.97% |
| 2014 FY | - MYR | -16.61% |
| 2014 Q2 | 7.36 Million MYR | 246.64% |
| 2014 Q1 | 2.12 Million MYR | -75.3% |
| 2013 Q2 | 4.89 Million MYR | 212.92% |
| 2013 Q3 | 10.32 Million MYR | 111.05% |
| 2013 Q4 | 8.6 Million MYR | -16.7% |
| 2013 FY | - MYR | 10.87% |
| 2013 Q1 | 1.56 Million MYR | -85.4% |
| 2012 Q3 | 8.44 Million MYR | 198.09% |
| 2012 FY | - MYR | 15.67% |
| 2012 Q1 | 906 Thousand MYR | -89.45% |
| 2012 Q4 | 10.71 Million MYR | 26.81% |
| 2012 Q2 | 2.83 Million MYR | 212.8% |
| 2011 Q1 | 3.24 Million MYR | 25.22% |
| 2011 Q2 | 3.93 Million MYR | 21.1% |
| 2011 Q4 | 8.58 Million MYR | 124.44% |
| 2011 FY | - MYR | 135.09% |
| 2011 Q3 | 3.82 Million MYR | -2.7% |
| 2010 FY | - MYR | -48.76% |
| 2010 Q2 | -972 Thousand MYR | 0.0% |
| 2010 Q3 | -426 Thousand MYR | 56.17% |
| 2010 Q4 | 2.59 Million MYR | 708.69% |
| 2009 Q4 | 4.9 Million MYR | 116.95% |
| 2009 Q3 | 2.25 Million MYR | 0.0% |
| 2009 FY | - MYR | 33.59% |
| 2008 FY | - MYR | 16.5% |
| 2007 FY | - MYR | -9.31% |
| 2006 FY | - MYR | 0.13% |
| 2005 FY | - MYR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Duopharma Biotech Berhad | 124.51 Million MYR | 43.152% |